[PEL-BIOTECH-Inc] March 2026 Monthly Revenue NT$2M (YoY +74.5%)
Key facts
- [PEL-BIOTECH-Inc] March 2026 Monthly Revenue NT$2M (YoY +74.5%)
- PEL-BIOTECH-Inc announced its monthly revenue for March 2026. Although the amount was small at NT$2 million, it recorded a significant 74.5% increase year-over-year, showing signs of rapid growth.
- Source: PR Times
- Date: March 1, 2026
Direct answer
PEL-BIOTECH-Inc announced its monthly revenue for March 2026. Although the amount was small at NT$2 million, it recorded a significant 74.5% increase year-over-year, showing signs of rapid growth.
- Citation
- [PEL-BIOTECH-Inc] March 2026 Monthly Revenue NT$2M (YoY +74.5%) (March 1, 2026), PR Times
- Source
- PR Times
- Date
- March 1, 2026
PEL-BIOTECH-Inc announced its monthly revenue for March 2026. Although the amount was small at NT$2 million, it recorded a significant 74.5% increase year-over-year, showing signs of rapid growth.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 13, 2026 at 11:43 (19h 13m after Collected)
Company Code: 6949
Company Name: PEL-BIOTECH-Inc
Industry: Biotechnology and Medical Care
Data Month: 2026-03
Monthly Revenue: 2,454 thousand TWD (0.002 billion)
Year-over-year Change: +74.5%
Company Name: PEL-BIOTECH-Inc
Industry: Biotechnology and Medical Care
Data Month: 2026-03
Monthly Revenue: 2,454 thousand TWD (0.002 billion)
Year-over-year Change: +74.5%
FAQ
What are the key facts in this article?
PEL-BIOTECH-Inc announced its monthly revenue for March 2026. Although the amount was small at NT$2 million, it recorded a significant 74.5% increase year-over-year, showing signs of rapid growth.
What is the direct answer?
PEL-BIOTECH-Inc announced its monthly revenue for March 2026. Although the amount was small at NT$2 million, it recorded a significant 74.5% increase year-over-year, showing signs of rapid growth.
What is the source and date?
PR Times: https://openapi.twse.com.tw/revenue/twse-rev-6949-11503 | March 1, 2026